Q-omics provides the consensus-scored CYP4F9P profile across patient tissues and cancer cell-line models. CYP4F9P expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, CYP4F9P RNA expression shows 6,307 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KIRC, and STAD as cancer lineages where CYP4F9P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for CYP4F9P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes CYP4F9P survival associations across molecular data types. CYP4F9P RNA expression shows survival associations in the most cancer types (12). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

CYP4F9P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	12	KIRC (54)	view →

This table ranks reproducible CYP4F9P RNA expression–survival associations across cancer types. High CYP4F9P expression shows unfavorable associations in KIRC, LUSC, DLBC and OV, but favorable associations in LAML and GBM. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .006). Together, the overview and detailed table identify KIRC as the clearest survival context for CYP4F9P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	III,IV	0.551	0.769	.006	54	view →
LUSC	OS	Tertile	III,IV	0.201	0.688	.007	36	view →
LAML	DFS	Tertile	All	0.646	0.284	.003	34	view →
GBM	DFS	Tertile	All	0.480	0.184	.014	27	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
OV	OS	Tertile	All	0.212	0.330	.018	18	view →

Pink = unfavorable, green = favorable. all 12 lineages →

CYP4F9P-KIRC (DFS)

Kaplan–Meier survival curve for CYP4F9P RNA expression in KIRC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with CYP4F9P in patient tissues and cancer cell lines. In patient samples, CYP4F9P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,307	STAD (5984)	view →
RNA	2,458	HNSC (619)	view →